Search Results 751-760 of 12608 for Arsenic

  1. Clinical trials - Gastroenterology and Hepatology

    Mayo Clinic's Division of Gastroenterology and Hepatology offers treatment and specialty care for people with a wide range of rare and common digestive ...

  2. Bone cancer - Doctors and departments - Mayo Clinic

    Bone cancer most commonly affects the long bones in the arms and legs. Some types happen mostly in children, while others affect mostly adults.

  3. Urology - Clinical trials

    Levels of bladder cancer-derived extracellular vesicles become undetectable after radical cystectomy in patients with localized bladder cancer. This study hopes ...

  4. IL-2 plus FOLFOX and Nivolumab for Treatment of Peritoneal Metastases - Mayo Clinic

    The purpose of this study is to evaluate the reduction in the peritoneal carcinomatosis index (PCI) after completion of the study treatment. Participation ...

  5. Bone cancer - Doctors and departments - Mayo Clinic

    Bone cancer most commonly affects the long bones in the arms and legs. Some types happen mostly in children, while others affect mostly adults.

  6. Bone cancer - Doctors and departments - Mayo Clinic

    Bone cancer most commonly affects the long bones in the arms and legs. Some types happen mostly in children, while others affect mostly adults.

  7. Gastroenterology and Hepatology - Clinical trials

    Rochester, Minn. The purpose of this study is to create a registry of obese patients who have been phenotyped to understand the heterogeneity of obesity. Celiac ...

  8. Bone cancer - Doctors and departments - Mayo Clinic

    Bone cancer most commonly affects the long bones in the arms and legs. Some types happen mostly in children, while others affect mostly adults.

  9. Bone cancer - Doctors and departments - Mayo Clinic

    Bone cancer most commonly affects the long bones in the arms and legs. Some types happen mostly in children, while others affect mostly adults.

  10. Clinical trials - Oncology (Medical)

    The purpose of this study is to evaluate the safety and effectiveness of nonconforming idecabtagene vicleucel (ide-cel) in subjects with multiple myeloma per ...